- Home
- XAIR vs INKT Comparison
XAIR vs INKT Comparison
Compare XAIR & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XAIR
- INKT
- Stock Information
- Founded
- XAIR 2011
- INKT 2017
- Country
- XAIR United States
- INKT United States
- Employees
- XAIR N/A
- INKT N/A
- Industry
- XAIR Medical/Dental Instruments
- INKT Medicinal Chemicals and Botanical Products
- Sector
- XAIR Health Care
- INKT Health Care
- Exchange
- XAIR Nasdaq
- INKT Nasdaq
- Market Cap
- XAIR 26.0M
- INKT 28.5M
- IPO Year
- XAIR N/A
- INKT 2021
- Fundamental
- Price
- XAIR $0.42
- INKT $0.88
- Analyst Decision
- XAIR Strong Buy
- INKT Strong Buy
- Analyst Count
- XAIR 4
- INKT 2
- Target Price
- XAIR $3.67
- INKT $6.50
- AVG Volume (30 Days)
- XAIR 2.3M
- INKT 213.1K
- Earning Date
- XAIR 02-10-2025
- INKT 11-14-2024
- Dividend Yield
- XAIR N/A
- INKT N/A
- EPS Growth
- XAIR N/A
- INKT N/A
- EPS
- XAIR N/A
- INKT N/A
- Revenue
- XAIR $2,342,000.00
- INKT N/A
- Revenue This Year
- XAIR $230.80
- INKT N/A
- Revenue Next Year
- XAIR $265.55
- INKT N/A
- P/E Ratio
- XAIR N/A
- INKT N/A
- Revenue Growth
- XAIR 685.91
- INKT N/A
- 52 Week Low
- XAIR $0.30
- INKT $0.46
- 52 Week High
- XAIR $2.17
- INKT $1.90
- Technical
- Relative Strength Index (RSI)
- XAIR 51.29
- INKT 59.64
- Support Level
- XAIR $0.34
- INKT $0.74
- Resistance Level
- XAIR $0.38
- INKT $0.91
- Average True Range (ATR)
- XAIR 0.06
- INKT 0.12
- MACD
- XAIR 0.00
- INKT 0.01
- Stochastic Oscillator
- XAIR 40.62
- INKT 51.99
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.